{
    "Trade/Device Name(s)": [
        "cobas c Tina-quant Lipoprotein (a) Gen.2 assay",
        "Preciset Lp(a) Gen.2 calibrator set",
        "PreciControl Lp(a) Gen.2 control set",
        "cobas c Tina-quant Lipoprotein (a) Gen.2 Test System"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K122722",
    "Predicate Device Reference 510(k) Number(s)": [
        "K013359",
        "K082488"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFC",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "August 31, 2012",
    "Summary Letter Received Date": "September 5, 2012",
    "Submission Date": "November 28, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.5600",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Low Density Lipoprotein Immunological Test System",
        "Calibrator, secondary",
        "Single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Lipoprotein (a)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Li-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas c 501 analyzer",
        "Roche/Hitachi cobas c systems"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Test System"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics cobas c Tina-quant Lipoprotein (a) Gen.2 Test System for quantitative determination of Lp(a) in serum and plasma using immunoturbidimetry",
    "Indications for Use Summary": "Quantitative determination of lipoprotein(a) in human serum and plasma to evaluate lipid metabolism disorders and assess atherosclerotic cardiovascular disease, including calibration and quality control on Roche clinical chemistry analyzers",
    "fda_folder": "Immunology"
}